8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                            ------------------------

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

      Date of Report (Date of the earliest event reported): April 17, 2007

                                  Aspyra, Inc.
             (Exact Name of Registrant as Specified in Its Charter)

         California                  0-12551                     95-3353465
(State or Other Jurisdiction       (Commission                  (IRS Employer
      of Incorporation)            File Number)              Identification No.)

                               26115-A Mureau Road
                               Calabasas, CA 91302
               (Address of Principal Executive Offices) (Zip Code)

                                 (818) 880-6700
              (Registrant's Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_|  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

|_|  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

|_|  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

|_|  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))


                                     - 1 -



Item 2.02 Results of Operations and Financial Condition.

     On April 17, 2007, Aspyra, Inc. issued a press release announcing its
operating and financial results for the fourth quarter and fiscal year ended
December 31, 2006. A copy of the Press Release is attached hereto as Exhibit
99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

     The information in this Current Report on Form 8-K and the Exhibits
attached hereto shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall they
be deemed incorporated by reference in any filing under the Securities Act of
1933, as amended, or the Exchange Act, except as shall be expressly set forth by
specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

     (d)  Exhibits.

Exhibit
Number                       Description of Exhibit
- -------       ------------------------------------------------------------------

 99.1         Aspyra, Inc. Press Release issued April 17, 2007.


                                     - 2 -



                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


April 17, 2007                             Aspyra, Inc.

                                           /s/ Steven M. Besbeck
                                           -------------------------------------
                                           Steven M. Besbeck
                                           President and Chief Executive Officer


                                     - 3 -



                                  EXHIBIT INDEX

Exhibit
Number                       Description of Exhibit
- -------       ------------------------------------------------------------------

 99.1         Aspyra, Inc. Press Release issued April 17, 2007.


                                     - 4 -

EX-99.1

                                                                    Exhibit 99.1

                  Aspyra Reports Results of Operations for the
             Fourth Quarter and Fiscal Year Ended December 31, 2006


    CALABASAS, Calif.--(BUSINESS WIRE)--April 17, 2007--Aspyra, Inc.
(AMEX:APY), a provider of clinical and diagnostic information systems
for the healthcare industry, today reported its results of operations
for the fourth quarter and fiscal year ended December 31, 2006.

    Sales were $3,487,280 for the fourth quarter and the Company
incurred a net loss of $482,477 or basic and diluted net loss per
share of $.04 compared to sales of $2,096,790 for the fourth quarter
ended December 31, 2005, and the Company incurred a net loss of
$1,003,261 or basic and diluted net loss per share of $.17.

    For the fiscal year sales were $12,689,217 and the company
incurred a net loss of $3,570,438 or basic and diluted net loss per
share of $.36, compared to sales of $7,205,757 and a net loss of
$2,501,915 or basic and diluted net loss per share of $.62 for the
fiscal year ended December 31, 2005. In fiscal 2006 there were
9,914,916 basic and diluted shares outstanding compared to 4,038,233
basic and diluted shares outstanding in fiscal 2005.

    Steven M. Besbeck stated, "The results of operations for fiscal
2006 were for the first full year of operation since the consummation
of the merger between the Company and Aspyra Diagnostic Solutions,
Inc., formerly StorCOMM, Inc., on November 22, 2005. We substantially
completed the integration of the businesses during the past fiscal
year and incurred losses which were primarily attributable to the
costs of integrating the businesses which are fully discussed in the
Company's annual report on Form 10-KSB which was filed today. We look
forward to improved operating results later this fiscal year."

    Aspyra is a global provider of Health Care Information Technology
(HCIT) solutions and services to the healthcare industry. The Company
specializes in Clinical Information Systems (CIS), Picture Archive
Communication Systems (PACS) and Clinical Image Management Systems
(CIMS) for hospitals, multi-specialty clinics, clinical laboratories,
imaging departments and centers, orthopedic environments and
pharmacies. Aspyra's highly scalable systems can be installed
standalone or integrated to provide a single-vendor, enterprise-wide
solution. For more information on Aspyra, its products and services,
visit www.aspyra.com.

    Safe Harbor Statement

    This press release includes forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including statements related to anticipated revenues, expenses,
earnings, operating cash flows, the outlook for Aspyra's markets and
the demand for its products. Forward-looking statements are not
guarantees of future performance and are inherently subject to
uncertainties and other factors which could cause actual results to
differ materially from the forward-looking statement. Such statements
are based upon, among other things, assumptions made by, and
information currently available to, management as of today April 17,
2007, including management's own knowledge and assessment of the
Company's industry and competition. Factors that could cause Aspyra's
actual results to differ materially from these forward-looking
statements include among others: whether the combined company will
realize the potential benefits of the merger; the competitive
environment; unexpected technical and marketing difficulties inherent
in major product development efforts; the potential need for changes
in our long-term strategy in response to future developments; future
advances in clinical information technology and procedures, as well as
potential changes in government regulations and healthcare policies;
and rapid technological change in the microelectronics and software
industries. The Company refers interested persons to its most recent
Annual Report on Form 10-KSB and its other SEC filings for a
description of additional uncertainties and factors, which may affect
forward-looking statements. The Company assumes no duty to update its
forward-looking statements.



    CONTACT: Aspyra, Inc.
             Steven M. Besbeck, President and CEO
             818-880-6700, x8660